Registration of securities issued in business combination transactions

Condensed Statements of Cash Flows

v3.21.2
Condensed Statements of Cash Flows - USD ($)
2 Months Ended 6 Months Ended
Dec. 31, 2020
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (8,996) $ 771,059
Adjustments to reconcile net income to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account   (5,315)
Offering costs allocated to warrants   359,874
Change in fair value of warrant liability   (1,494,077)
Changes in operating assets and liabilities:    
Prepaid assets (2,558) (177,609)
Accrued expenses 1,222 81,657
Net cash used in operating activities (10,032) (464,411)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account   (116,150,000)
Net cash used in investing activities   (116,150,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts   113,470,500
Proceeds from sale of Private Placement Units   4,172,000
Proceeds from sale of representative shares   2,105
Repayment of promissory note – related party   (150,000)
Payment of deferred offering costs (80,132) (208,227)
Net cash provided by financing activities 94,868 117,286,378
Net change in cash 84,836 671,967
Cash, beginning of period 84,836
Cash, end of the period 84,836 756,803
Supplemental disclosure of cash flow information:    
Initial value of common stock subject to possible redemption   101,131,827
Change in initial value of common stock subject to possible redemption   1,055,672
Initial recognition of warrant liability   7,025,183
Deferred underwriters’ discount payable charged to additional paid-in capital   4,220,500
Change in accrued offering costs   $ 84,979
Proceeds from issuance of founder shares 25,000  
Proceeds from issuance of promissory note to related party 150,000  
Deferred offering costs included in accrued offering costs and expenses $ 154,979